Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on asymmetric catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105316250A reveals Empedobacter brevis strain for high-purity chiral alcohols. Offers cost reduction and scalable supply for pharmaceutical intermediates.
Patent CN102659815A reveals efficient Ticagrelor synthesis via new intermediates. Reduces steps and improves scalability for reliable API supplier partnerships.
Novel axially chiral ligand enables high-yield asymmetric synthesis. Reduces costs and improves supply chain reliability for chiral aminoamide manufacturing.
Novel cobalt-catalyzed asymmetric hydrosilylation patent CN116554223A offers high enantioselectivity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN109232494B reveals a superior (S)-BINAL-H reduction method for bimatoprost intermediates, offering enhanced chiral purity and streamlined manufacturing for global supply chains.
Patent CN101885742B discloses a novel chiral bisphosphorodiamidate catalyst enabling high enantioselectivity in nitrile silicification, offering robust supply chain solutions.
Patent CN103012445A details a novel chiral zinc complex enabling efficient asymmetric catalysis. This report analyzes its scalable synthesis and cost-reduction potential for fine chemical manufacturing.
Patent CN102167674A details a mild iridium-catalyzed method for synthesizing optically pure 3-aryl sulfur-substituted propenes, offering significant supply chain advantages.
Patent CN121378129A reveals novel binaphthyl ligands for asymmetric catalysis. Enhance enantioselectivity and streamline pharmaceutical intermediate manufacturing supply chains.
Patent CN109956946B details a novel iridium-catalyzed method for synthesizing chiral amines with high enantioselectivity, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel synthesis of binaphthyl NN-dioxide ligands via Pd-catalyzed carbonylation. High yield over 75 percent and purity exceeding 95 percent. Reliable supplier for asymmetric catalysis.
Patent CN120554424A reveals a novel ferrocene-based P,N,N-ligand offering superior stability and stereoselectivity for cost-effective pharmaceutical intermediate manufacturing.
Patent CN111349081B reveals a chiral protonic acid catalyzed Ugi reaction for Ivosidenib, eliminating chiral columns and toxic solvents for scalable manufacturing.
Patent CN102199130A details a robust zinc-catalyzed route for chiral oxazoline, offering cost-effective solutions for reliable pharmaceutical intermediate suppliers.
Patent CN110551032B details a high-efficiency iridium-catalyzed asymmetric reductive amination method, offering significant cost reduction in agrochemical manufacturing and reliable supply chain solutions.
Patent CN101412738A details a novel iron-catalyzed asymmetric O-H insertion. This technology offers cost-effective, high-enantioselectivity routes for API intermediates.
Patent CN105879905A introduces a novel chiral phosphine catalyst enabling high enantioselectivity in cross Rauhut-Currier reactions, offering significant supply chain and cost advantages.
Patent CN102399165B reveals a high-yield Chloramphenicol synthesis using nitromethane, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN109851634B discloses Yu-Phos ligands for asymmetric catalysis. Enables cost reduction in pharmaceutical intermediate manufacturing with high stereoselectivity.
Patent CN111138350B reveals a high-yield asymmetric synthesis route for dexchlorpheniramine, offering significant cost reduction and supply chain reliability for API manufacturers.